Fig. 5From: Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trialComparison between cfDNA and AFP levels in three cases corresponding to patients showing different clinical characteristics. Panels a, b and c represent the described clinical cases of patients B, E and K, respectivelyBack to article page